Infantile-Onset Myelin Protein Zero–Related Demyelinating Neuropathy Presenting as an Upper Extremity Monoplegia☆,☆☆
Introduction
Early-onset demyelinating neuropathies in childhood are uncommon and present a considerable diagnostic challenge. Although most have a genetic basis, acquired inflammatory neuropathies can also occur in early infancy. We report a child who presented in infancy with an upper extremity monoplegia, but who had widespread slowing of nerve conduction on neurophysiologic testing. Although a diagnosis of infantile chronic inflammatory demyelinating polyneuropathy was initially considered, features on the nerve biopsy were more consistent with an inherited neuropathy, and she was ultimately found to have a de novo heterozygous mutation of the myelin protein zero (MPZ) gene.
Section snippets
Case Report
An 11-month-old female infant was referred with a 5-month history of decreased spontaneous movement of the left upper limb and generalized hypotonia. From 6 months of age, her parents noted decreasing use of the left upper limb. She reached across the midline with her right upper limb to grasp objects. Although she could hold objects placed directly into her left hand, she had no proximal movement and was unable to reach for toys on the left side. Hypotonia was also noted from the first 2
Discussion
This patient has an infantile-onset demyelinating neuropathy due to a de novo mutation in the MPZ gene. Demyelinating neuropathies of infantile onset are uncommon, have a broad differential diagnosis, and usually have a genetic basis. Genetic causes include early-onset forms of demyelinating CMT, as well as neuropathies associated with a range of metabolic conditions and disorders of central nervous system myelin.3
The terminology used to define the etiology of early-onset demyelinating
References (20)
- et al.
Conduction block and tonic pupils in Charcot-Marie-Tooth disease caused by a myelin protein zero p.Ile112Thr mutation
Neuromuscul Disord
(2011) - et al.
Inter-nerves and intra-nerve conduction heterogeneity in CMTX with Arg(15)Gln mutation
Clin Neurophysiol
(2004) - et al.
Two divergent types of nerve pathology in patients with different P0 mutations in Charcot-Marie-Tooth disease
Neurology
(1996) - et al.
Validation of the Charcot-Marie-Tooth disease pediatric scale as an outcome measure of disability
Ann Neurol
(2012) - et al.
Demyelinating prenatal and infantile developmental neuropathies
J Peripher Nerv Syst
(2012) - et al.
The hypertrophic forms of hereditary motor and sensory neuropathy. A study of hypertrophic Charcot-Marie-Tooth disease (HMSN type I) and Dejerine-Sottas disease (HMSN type III) in childhood
Brain
(1987) Dejerine-Sottas syndrome grown to maturity: Overview of genetic and morphological heterogeneity and follow-up of 25 patients
J Anat
(2002)- et al.
The range of chronic demyelinating neuropathy of infancy: A clinico-pathological and genetic study of 15 unrelated cases
J Neurol
(2001) - et al.
Steroid responsive polyneuropathy in a family with a novel myelin protein zero mutation
J Neurol Neurosurg Psychiatry
(2000) - et al.
Asymmetric phenotype associated with rare myelin protein zero mutation
J Clin Neuromuscul Dis
(2010)
Cited by (0)
- ☆
Institution where the work was performed: Department of Neurology, Royal Children׳s Hospital, Melbourne, Australia.
- ☆☆
E.M.Y. is supported by a National Health Medical Research Council, Australia (NHMRC) Early Career Fellowship (APP1073323). G.A.N. receives Grant support from the National Health Medical Research Council, Australia (APP104668). M.M.R. receives Grant support from the National Health Medical Research Council, Australia under The Centres of Research Excellence scheme (APP1031893). This work was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS.